Poor improvement of on-treatment FIB-4 index after initiation of nucleos(t)ide analogs is associated with development of hepatocellular carcinoma in both cirrhotic and non-cirrhotic chronic hepatitis B patients

被引：0
|
作者：
Murakawa, Miyako [1 ,2 ]
Shimizu, Taro [1 ]
Takeichi, Eiko [1 ]
Tsuchiya, Jun [1 ]
Sato, Ayako [1 ]
Miyoshi, Masato [1 ]
Kawai-Kitahata, Fukiko [1 ]
Nitta, Sayuri [1 ]
Itsui, Yasuhiro [1 ]
Nakagawa, Mina [1 ]
Azuma, Seishin [1 ]
Kakinuma, Sei [1 ,3 ]
Asahina, Yasuhiro [1 ,3 ]
机构：
[1] Tokyo Med & Dent Univ, Gastroenterol & Hepatol, Tokyo, Japan
[2] Tokyo Med & Dent Univ, Clin Lab, Tokyo, Japan
[3] Tokyo Med & Dent Univ, Liver Dis Control, Tokyo, Japan
来源：
JOURNAL OF HEPATOLOGY | 2020年 / 73卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
FRI395
引用
收藏
页码：S592 / S593
页数：2
相关论文
共 50 条
  • [1] FIB-4 index and serum α-fetoprotein are useful predictors of hepatocellular carcinoma occurrence in hepatitis B patients with nucleos(t)ide analogs therapy
    Kuwano, Akifumi
    Miyazaki, Masayuki
    Yada, Masayoshi
    Tanaka, Kosuke
    Koga, Yuta
    Masumoto, Akihide
    Motomura, Kenta
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2023, 26 (03)
  • [2] Determinants of hepatocellular carcinoma in cirrhotic patients treated with nucleos(t)ide analogues for chronic hepatitis B
    Hsu, Yao-Chun
    Wu, Chun-Ying
    Lane, Hsien-Yuan
    Chang, Chi-Yang
    Tai, Chi-Ming
    Tseng, Cheng-Hao
    Lo, Gin-Ho
    Perng, Daw-Shyong
    Lin, Jaw-Town
    Mo, Lein-Ray
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2014, 69 (07) : 1920 - 1927
  • [3] USEFULNESS OF FIB-4 INDEX AND ALT AT 1 YEAR OF NUCLEOS(T) IDE ANALOG TREATMENT FOR PREDICTION OF HEPATOCELLULAR CARCINOMA IN CHRONIC HEPATITIS B PATIENTS
    Inoue, Jun
    Akahane, Takehiro
    Kobayashi, Tomoo
    Kimura, Osamu
    Sato, Kosuke
    Ninomiya, Masashi
    Iwata, Tomoaki
    Takai, Satoshi
    Kisara, Norihiro
    Sato, Toshihiro
    Nagasaki, Futoshi
    Miura, Masahito
    Nakamura, Takuya
    Umetsu, Teruyuki
    Sano, Akitoshi
    Tsuruoka, Mio
    Onuki, Masazumi
    Sawahashi, Satoko
    Niitsuma, Hirofumi
    Masamune, Atsushi
    HEPATOLOGY, 2023, 78 : S550 - S550
  • [4] FIB-4, not APRI predicts the regression of fibrosis in chronic hepatitis B patients treated with nucleos(t)ide analogs.
    Kapuria, Devika
    Surana, Pallavi
    Ben-Yakov, Gil S.
    Heller, Theo
    Liang, T. Jake
    Hoofnagle, Jay H.
    Takyar, Varun K.
    Kleiner, David E.
    Koh, Christopher
    HEPATOLOGY, 2017, 66 : 1027A - 1027A
  • [5] Cessation of Nucleos(t)ide Analogue treatment after HBeAg seroconversion is associated with a 4-fold increased risk of relapse in cirrhotic compared to non-cirrhotic patients
    Van Hees, Stijn
    Bourgeois, Stefan
    Van Vlierberghe, Hans
    Serste, Thomas
    Francque, Sven
    Michielsen, Peter P.
    Dirk, Sprengers
    Reynaert, Hendrik
    Henrion, Jean
    Dastis, Sergio Negrin
    Delwaide, Jean
    Lasser, Luc
    Decaestecker, Jochen
    Orlent, Hans
    Janssens, Filip
    Robaeys, Geert
    Colle, Isabelle
    Starkel, Peter
    Moreno, Christophe
    Nevens, Frederik
    Vanwolleghem, Thomas
    HEPATOLOGY, 2017, 66 : 500A - 500A
  • [6] Cessation of Nucleos(t)ide Analogue Therapy in Non-Cirrhotic Hepatitis B Patients with Prior Severe Acute Exacerbation
    Lai, Chia-Yeh
    Yang, Sheng-Shun
    Lee, Shou-Wu
    Tsai, Hsin-Ju
    Lee, Teng-Yu
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (21)
  • [7] Influence of insulin resistance on the development of hepatocellular carcinoma after antiviral treatment for non-cirrhotic patients with chronic hepatitis C
    Hayashi, Takeo
    Ogawa, Eiichi
    Furusyo, Norihiro
    Murata, Masayuki
    Hayashi, Jun
    INFECTIOUS AGENTS AND CANCER, 2016, 11
  • [8] Influence of insulin resistance on the development of hepatocellular carcinoma after antiviral treatment for non-cirrhotic patients with chronic hepatitis C
    Takeo Hayashi
    Eiichi Ogawa
    Norihiro Furusyo
    Masayuki Murata
    Jun Hayashi
    Infectious Agents and Cancer, 11
  • [9] On-treatment risks of cirrhosis and hepatocellular carcinoma among a large cohort of predominantly non- Asian patients with non-cirrhotic chronic hepatitis B
    Yang, Zeyuan
    Cheung, Ramsey C.
    Chitnis, Amit S.
    Zhang, Wei
    Gish, Robert G.
    Wong, Robert J.
    JHEP REPORTS, 2023, 5 (10)
  • [10] Annual Incidence for Hepatocellular Carcinoma (HCC) in Non-Cirrhotic Patients With Chronic Hepatitis B (CHB) and Cirrhotic Patients of All Etiologies
    Do, Ailinh L.
    Wong, Carrie R.
    Nguyen, Vincent G.
    Garcia, Ruel T.
    Trinh, Huy N.
    Kin, Kevin
    Nguyen, Huy A.
    Nguyen, Khanh K.
    Levitt, Brian S.
    Nguyen, Mindie H.
    GASTROENTEROLOGY, 2011, 140 (05) : S920 - S920
12345